Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omega 3 Trial for Depression Initiated - Nutraceuticals World
Market Updates

Omega 3 Trial for Depression Initiated

Researchers at Cedars-Sinai Medical Center’s Department of Psychiatry and Behavioral Neurosciences are seeking participants for a clinical trial examining whether certain omega 3 fatty acids are effective treatments for depression, according to news-medical.net. The two fatty acids being studied are EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)—this is the first time a clinical trial will systematically test the two against each other and against placebo in a large sample of people with major depression. The National Institutes of Health (NIH) is sponsoring this study, which will recruit a total of 300 subjects between the ages of 18 and 80 who are experiencing significant symptoms of major depression but are otherwise in good health. News-medical.net says the study will go on for a period of five years. Participants will receive one of the two drugs or placebo for eight weeks in a randomized, double-blind manner.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters